NMN

What is NMN?

NMN (Nicotinamide Mononucleotide) is the immediate precursor to NAD+ — your body converts NMN directly into NAD+ in a single enzymatic step. This makes it theoretically more efficient than NR (Nicotinamide Riboside), which requires two conversion steps. Whether this translates to meaningful clinical differences is still debated, but NMN has become the preferred NAD+ precursor in the longevity community.

David Sinclair at Harvard has been the most prominent advocate, publicly stating he takes 1g of NMN daily. His research in mice showed remarkable age-reversal effects: old mice given NMN had the endurance, metabolism, and vascular health of young mice. The human translation is ongoing, with multiple clinical trials showing NMN safely raises NAD+ levels and improves various biomarkers.

The appeal is straightforward: NAD+ declines 50% between ages 40-60. This decline impairs DNA repair, mitochondrial function, and sirtuin activity. NMN replenishes NAD+ levels. Whether this actually extends human lifespan remains the billion-dollar question — but the mechanistic logic is sound and the early human data is encouraging.

How Does It Work?

NMN is transported into cells primarily via the Slc12a8 transporter (identified in 2019) and immediately converted to NAD+ by the enzyme NMNAT (nicotinamide mononucleotide adenylyltransferase). This one-step conversion is its advantage over NR, which must first be phosphorylated to NMN before the same NMNAT step.

Once converted to NAD+, it fuels sirtuins (SIRT1-7) for DNA repair and gene regulation, PARPs for DNA damage repair, CD38 for immune function, and mitochondrial complex I for energy production. Essentially, NMN replenishes the cofactor that hundreds of critical enzymes depend on.

What Does The Research Say?

Human clinical trials: A 2021 Washington University trial showed NMN improved muscle insulin sensitivity in prediabetic women. A 2022 Japanese trial showed improved physical performance in older men. Multiple trials confirm NMN safely raises blood NAD+ levels within 2-4 weeks.

Animal research is extensive: improved cardiovascular function, enhanced exercise capacity, better insulin sensitivity, neuroprotection, and lifespan extension in mice. The key caveat: mouse longevity does not always translate to human longevity. But the biomarker improvements in humans are genuine and measurable.

Reported Dosages

Clinical trials: 250mg-1200mg daily, orally.

David Sinclair reportedly takes 1000mg daily.

Most consumers use 250-500mg daily, taken in the morning (to align with circadian NAD+ peaks).

Sublingual forms may improve bioavailability.

Available as a legal supplement in most countries.

Side Effects & Risks

Generally well-tolerated. Mild GI discomfort in some users at higher doses, occasional mild headache initially. No serious adverse events reported in clinical trials. Theoretical concern: very high NAD+ levels could theoretically fuel cancer cell metabolism, though no evidence supports this at supplemental doses.

Legal Status by Country

Where to Buy NMN

Affiliate link — we may earn a small commission at no extra cost to you.